Jian‐Xiong Chen

3.4k total citations
94 papers, 2.7k citations indexed

About

Jian‐Xiong Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Jian‐Xiong Chen has authored 94 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 30 papers in Cardiology and Cardiovascular Medicine and 28 papers in Cancer Research. Recurrent topics in Jian‐Xiong Chen's work include Cancer, Hypoxia, and Metabolism (15 papers), Sirtuins and Resveratrol in Medicine (13 papers) and Lipid metabolism and disorders (12 papers). Jian‐Xiong Chen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (15 papers), Sirtuins and Resveratrol in Medicine (13 papers) and Lipid metabolism and disorders (12 papers). Jian‐Xiong Chen collaborates with scholars based in United States, China and Canada. Jian‐Xiong Chen's co-authors include Heng Zeng, Xiaochen He, Lanfang Li, Barbara Meyrick, Xuwei Hou, Qinhui Tuo, Han Su, Duan‐Fang Liao, Duan‐Fang Liao and Venkata Ramana Vaka and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Jian‐Xiong Chen

88 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Xiong Chen United States 33 1.2k 539 516 479 475 94 2.7k
Xiaoqiang Tang China 27 1.5k 1.3× 232 0.4× 402 0.8× 653 1.4× 300 0.6× 53 3.1k
Danny Ling Wang Taiwan 28 1.1k 1.0× 209 0.4× 478 0.9× 621 1.3× 327 0.7× 36 2.5k
Ming-Hui Zou United States 31 2.3k 1.9× 749 1.4× 790 1.5× 1.3k 2.7× 378 0.8× 38 4.8k
Cécile Vindis France 36 1.7k 1.4× 474 0.9× 341 0.7× 332 0.7× 471 1.0× 61 3.3k
Renu A. Kowluru United States 48 3.0k 2.6× 531 1.0× 252 0.5× 727 1.5× 711 1.5× 113 5.5k
Yunzhou Dong United States 23 1.5k 1.2× 418 0.8× 239 0.5× 544 1.1× 221 0.5× 47 2.4k
Changqing Xu China 36 1.6k 1.4× 392 0.7× 546 1.1× 675 1.4× 378 0.8× 115 3.2k
Richard Clements United States 30 1.1k 0.9× 414 0.8× 868 1.7× 550 1.1× 154 0.3× 80 2.7k
Alexander Akhmedov Switzerland 25 686 0.6× 400 0.7× 480 0.9× 307 0.6× 158 0.3× 49 2.0k
Sokrates Stein Switzerland 25 893 0.8× 365 0.7× 262 0.5× 534 1.1× 229 0.5× 38 2.4k

Countries citing papers authored by Jian‐Xiong Chen

Since Specialization
Citations

This map shows the geographic impact of Jian‐Xiong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Xiong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Xiong Chen more than expected).

Fields of papers citing papers by Jian‐Xiong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Xiong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Xiong Chen. The network helps show where Jian‐Xiong Chen may publish in the future.

Co-authorship network of co-authors of Jian‐Xiong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Xiong Chen. A scholar is included among the top collaborators of Jian‐Xiong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Xiong Chen. Jian‐Xiong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xuming, et al.. (2025). MYG1 interacts with HSP90 to promote breast cancer progression through Wnt/β-catenin and Notch signaling pathways. Experimental Cell Research. 446(1). 114448–114448. 2 indexed citations
2.
Pan, Lihong, Xiaochen He, Dongzhi Wang, et al.. (2025). PHD2 Deletion in CD8 + T Cells Worsens TAC-Induced Cardiac Inflammation, Heart Failure, and Pulmonary Remodeling. Hypertension. 82(11). 2040–2054.
4.
Chen, Jian‐Xiong, et al.. (2024). Knockout of Sirtuin 3 in endothelial cells impairs endothelial‐dependent relaxation and myogenic response in mice. Physiological Reports. 12(20). e70060–e70060. 1 indexed citations
5.
Xu, Rui, Xiaochen He, Lihong Pan, et al.. (2024). High selenium diet attenuates pressure overload-induced cardiopulmonary oxidative stress, inflammation, and heart failure. Redox Biology. 76. 103325–103325. 13 indexed citations
6.
He, Xiaochen, et al.. (2024). TIGAR Deficiency Blunts Angiotensin-II-Induced Cardiac Hypertrophy in Mice. International Journal of Molecular Sciences. 25(4). 2433–2433.
7.
Zheng, Lin, et al.. (2023). PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway. Cancer Science. 114(8). 3190–3202. 15 indexed citations
8.
Wei, Yicong, Yonghong Hu, Keming Qi, et al.. (2022). Dihydromyricetin improves LPS-induced sickness and depressive-like behaviors in mice by inhibiting the TLR4/Akt/HIF1a/NLRP3 pathway. Behavioural Brain Research. 423. 113775–113775. 28 indexed citations
9.
Chen, Jian‐Xiong & Heng Zeng. (2019). Deficiency of Sirtuin 3 Accentuates Angiotensin II‐Induced Arterial/Myocardial Stiffness and Hypertension. The FASEB Journal. 33(S1). 1 indexed citations
10.
Song, Wen, Jian‐Xiong Chen, Shiyu Duan, et al.. (2019). Silencing PSME3 induces colorectal cancer radiosensitivity by downregulating the expression of cyclin B1 and CKD1. Experimental Biology and Medicine. 244(16). 1409–1418. 16 indexed citations
11.
Chen, Jian‐Xiong, et al.. (2018). Effects, status and problems of liver transplantation in the treatment of portal hypertension. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 17(10). 976–980.
12.
He, Lu, Qionglin Zhou, Zheng Huang, et al.. (2018). PINK1/Parkin‐mediated mitophagy promotes apelin‐13‐induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions. Journal of Cellular Physiology. 234(6). 8668–8682. 105 indexed citations
13.
Sun, Shaowei, Juan Wen, Fei Qiu, et al.. (2016). Identification of the C-terminal domain of Daxx acts as a potential regulator of intracellular cholesterol synthesis in HepG2 cells. Biochemical and Biophysical Research Communications. 480(1). 139–145. 3 indexed citations
14.
Zeng, Heng, Xiaochen He, Qinhui Tuo, et al.. (2016). LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2α/Notch3 pathways. Scientific Reports. 6(1). 20931–20931. 89 indexed citations
15.
Zeng, Heng, Venkata Ramana Vaka, Xiaochen He, George W. Booz, & Jian‐Xiong Chen. (2015). High‐fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. Journal of Cellular and Molecular Medicine. 19(8). 1847–1856. 104 indexed citations
16.
Hou, Xuwei, et al.. (2015). Apelin Gene Therapy Increases Autophagy via Activation of Sirtuin 3 in Diabetic Heart. PubMed. 1(4). 84–91. 14 indexed citations
17.
Hou, Xuwei, Heng Zeng, Xiaochen He, & Jian‐Xiong Chen. (2014). Sirt3 is essential for apelin‐induced angiogenesis in post‐myocardial infarction of diabetes. Journal of Cellular and Molecular Medicine. 19(1). 53–61. 68 indexed citations
18.
Li, Lanfang, Heng Zeng, Xuwei Hou, Xiaochen He, & Jian‐Xiong Chen. (2013). Myocardial Injection of Apelin-Overexpressing Bone Marrow Cells Improves Cardiac Repair via Upregulation of Sirt3 after Myocardial Infarction. PLoS ONE. 8(9). e71041–e71041. 60 indexed citations
19.
Chen, Jian‐Xiong, et al.. (2008). Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice. Arteriosclerosis Thrombosis and Vascular Biology. 28(9). 1606–1613. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026